07/06/2024
Lupin Subsidiary Acquires Two Brands from Sanofi
This acquisition aligns with the company's strategy to expand its global presence in speciality areas.
Pharmaceutical major Lupin announced on Wednesday, June 5, that its European subsidiary has completed the acquisition of two brands from Sanofi.
In its regulatory filing, the company said that its subsidiary, Lupin Atlantis Holdings SA, has completed the acquisition of Aarane in Germany, Nalcrom in Canada and the Netherlands, and its associated trademark rights from Sanofi.
This acquisition aligns with the company’s strategy to expand its global presence in speciality areas, and will enhance the company’s respiratory business in Germany by aiding in the expansion of the newly established franchise with the introduction of Lufrobec.
Trading Company P Limited